Dolby director sells 1,000 shares in open-market trade
Dolby Laboratories director Emily Rollins reported an open-market sale of 1,000 shares of Class A common stock at $60.08 per share on April 1, 2026.
Rhea-AI Filing Summary
Dolby Laboratories director Emily Rollins reported an open-market sale of 1,000 shares of Class A common stock at $60.08 per share on April 1, 2026. After this transaction, she directly holds 12,541 shares of Class A common stock.
Her post-transaction holdings include 3,908 shares underlying restricted stock units that remain subject to forfeiture until they vest, meaning part of her reported position is tied to future service or performance conditions rather than fully vested stock.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 1,000 | $60.08 | $60K |
Footnotes (1)
- F1. Shares held following the reported transaction included 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Key Figures
Key Terms
open-market sale financial
Class A common stock financial
restricted stock units financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Dolby Laboratories (DLB) director Emily Rollins report on this Form 4?
Is Emily Rollins’ Dolby Laboratories (DLB) transaction classified as a buy or a sell?
Does the Form 4 show any Dolby (DLB) option exercises or derivative transactions by Emily Rollins?
AI-generated analysis. How Rhea-AI works. Not financial advice.